Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

5.9%

1 terminated out of 17 trials

Success Rate

93.3%

+6.8% vs benchmark

Late-Stage Pipeline

53%

9 trials in Phase 3/4

Results Transparency

43%

6 of 14 completed with results

Key Signals

6 with results93% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (4)
P 1 (1)
P 2 (2)
P 3 (5)
P 4 (4)

Trial Status

Completed14
Recruiting1
Terminated1
Not Yet Recruiting1

Trial Success Rate

93.3%

Benchmark: 86.6%

Based on 14 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT07748065Not ApplicableCompletedPrimary

Effect of Intra-Dialytic Muscle Energy Technique on Restless Leg Syndrome in Hemodialysis Patients

NCT07675109Not ApplicableRecruitingPrimary

Optimizing Extended-Duration (XD-) TOMAC Therapy for Restless Legs Syndrome (RLS)

NCT07561476Not ApplicableCompletedPrimary

Effectiveness of Matrix Rhythm Therapy for Restless Legs Syndrome

NCT07307482Not Yet RecruitingPrimary

Study on the Mechanism of Gut Microbiota Mediating Restless Legs Syndrome Through Iron Metabolism

NCT02826681Phase 2TerminatedPrimary

Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia

NCT03053427Phase 4CompletedPrimary

A Study of Oral Dosing of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients

NCT01981941Phase 4CompletedPrimary

Post-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients With Moderate Renal Impairment

NCT02397057Phase 3CompletedPrimary

Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLS

NCT00256854Phase 3Completed

Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)

NCT01823770Phase 4CompletedPrimary

Effect of Rotigotine Patch Treatment on Cardiovascular Markers in Idiopathic Restless Legs Syndrome

NCT01382901Phase 2CompletedPrimary

Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS)

NCT01494766Not ApplicableCompletedPrimary

Efficacy of Tyrosine in Restless Legs Syndrome

NCT00373542Phase 4CompletedPrimary

12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome

NCT00314860Phase 3Completed

RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole

NCT00363857Phase 3CompletedPrimary

A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome

NCT00748098Phase 3Completed

Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Disturbance

NCT01411124Phase 1CompletedPrimary

Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects

Showing all 17 trials

Research Network

Activity Timeline